期刊
EMBO JOURNAL
卷 33, 期 24, 页码 2906-2921出版社
WILEY
DOI: 10.15252/embj.201489293
关键词
central nervous system; IRF7; myeloid cells; phenotype-switch; TGF beta
资金
- European Research Council [309788]
- EU Seventh Framework Program HEALTH [279017]
- Israeli Science Foundation [1782/11]
- Human Frontiers Science Program
- Career Development Award
- European Research Council (ERC) [309788] Funding Source: European Research Council (ERC)
Tissue microenvironment influences the function of resident and infiltrating myeloid-derived cells. In the central nervous system (CNS), resident microglia and freshly recruited infiltrating monocyte-derived macrophages (mo-M Phi) display distinct activities under pathological conditions, yet little is known about the microenvironment-derived molecular mechanism that regulates these differences. Here, we demonstrate that long exposure to transforming growth factor-beta 1 (TGF beta 1) impaired the ability of myeloid cells to acquire a resolving anti-inflammatory phenotype. Using genome-wide expression analysis and chromatin immunoprecipitation followed by next-generation sequencing, we show that the capacity to undergo pro-to anti-inflammatory (M1-to- M2) phenotype switch is controlled by the transcription factor interferon regulatory factor 7 (IRF7) that is down-regulated by the TGFb1 pathway. RNAi-mediated perturbation of Irf7 inhibited the M1-to-M2 switch, while IFN beta 1 (an IRF7 pathway activator) restored it. In vivo induction of Irf7 expression in microglia, following spinal cord injury, reduced their pro-inflammatory activity. These results highlight the key role of tissue-specific environmental factors in determining the fate of resident myeloid-derived cells under both physiological and pathological conditions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据